Anna Cruceta

2 articles listing Anna Cruceta in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial Nature Communications
2. Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial Nature Communications